In particular, in breast cancer, recentwhole-genome and whole-exome sequencing studies have consistently identified pointmutations and deletions of RUNX1 in human luminal breast cancers (Banerji et al., 2012; Cancer Genome Atlas Network, 2012; Ellis et al., 2012). This evidence concerns the gene RUNX1 and breast carcinoma.